Opening the floodgates of the immune system could help the body fight cancer. As described in a previous installment, researchers at the Baylor College of Medicine successfully eliminated breast and prostate tumors in mice by altering the expression of a specific protein in their regulatory T cells. Peering deeper, this piece will explore the foundations of this discovery: what role SRC-3, the critical protein, plays in regulatory T cells and how this knowledge could build towards a treatment for solid tumors.
Mayo’s Franklyn Prendergast dies at 78
Dr. Franklyn Prendergast, former Director of the Mayo Clinic Comprehensive Cancer Center, dies at 78.
